Eugene Goldwasser Dies | GenomeWeb

Eugene Goldwasser, who isolated and purified erythropoietin in the 1970s, has died, reports The New York Times. He was 88. It later became the basis of Amgen, and the company has made billions of dollars on the anemia drug. "It just continually delighted him that the work he did ended up having an impact on patients," Gary Toback, a colleague of Goldwasser's at the University of Chicago, tells the Times.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.